MRSN
Mersana Therapeutics Inc.
Company Overview
| Mkt Cap | $51.05M | Price | $9.58 |
| Volume | 35.05K | Change | +3.01% |
| P/E Ratio | -0.7 | Open | $9.30 |
| Revenue | $40.5M | Prev Close | $9.30 |
| Net Income | $-69.2M | 52W Range | $5.21 - $70.75 |
| Div Yield | N/A | Target | $28.29 |
| Overall | 46 | Value | 40 |
| Quality | 44 | Technical | 54 |
No chart data available
Stock Overview
Updated DailyMersana Therapeutics Inc. (MRSN) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.58 with a market capitalization of $51.05 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows MRSN with a volume of 35K shares. The stock opened down 0.00% from yesterday's close of $9.30. Current analyst estimates project earnings of $-1.07 per share for this year, with next year targeting $-6.42.
MRSN demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for MRSN include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 195.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:33 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRSN | $9.58 | +3.0% | 35.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mersana Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW